Global Rapid Microbiological Burden Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07242765

Publication Date:

July 8, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Rapid Microbiological Burden Testing refers to the swift identification and quantification of microbial contamination in a given sample or environment. This process typically involves the use of advanced technologies such as molecular biology techniques, immunological assays, or automated microbial detection systems. By quickly identifying the presence and level of microbial contamination, rapid microbiological burden detection enables timely interventions to prevent the spread of pathogens, ensure product quality in industries like food and pharmaceuticals, and maintain safety in various settings such as healthcare facilities and environmental monitoring.
The global Rapid Microbiological Burden Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淩apid Microbiological Burden Testing Industry Forecast鈥� looks at past sales and reviews total world Rapid Microbiological Burden Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Microbiological Burden Testing sales for 2023 through 2029. With Rapid Microbiological Burden Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Microbiological Burden Testing industry.
This Insight Report provides a comprehensive analysis of the global Rapid Microbiological Burden Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rapid Microbiological Burden Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Rapid Microbiological Burden Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Microbiological Burden Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Microbiological Burden Testing.
United States market for Rapid Microbiological Burden Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Rapid Microbiological Burden Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Rapid Microbiological Burden Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Rapid Microbiological Burden Testing players cover Boehringer Ingelheim International GmbH, Zoetis, Inc., Merck & Co., Inc., Bimeda, Inc., Elanco Animal Health, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Microbiological Burden Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instruments
Reagents & Kits
Consumables
Segmentation by Application:
Industrial Testing
Clinical Disease Diagnosis
Research Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Instruments
Reagents & Kits
Consumables
Segmentation by Application:
Industrial Testing
Clinical Disease Diagnosis
Research Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim International GmbH
Zoetis, Inc.
Merck & Co., Inc.
Bimeda, Inc.
Elanco Animal Health, Inc.
Virbac
Ceva Sante Animale
CZ Vaccines S.A.U. (Zendal Health S.A.)
Indian Immunologicals Ltd. (National Dairy Development Board)
Vaxxinova International BV (EW Group)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid Microbiological Burden Testing Market Size 2019-2030
2.1.2 Rapid Microbiological Burden Testing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Rapid Microbiological Burden Testing by Country/Region, 2019, 2023 & 2030
2.2 Rapid Microbiological Burden Testing Segment by Type
2.2.1 Instruments
2.2.2 Reagents & Kits
2.2.3 Consumables
2.3 Rapid Microbiological Burden Testing Market Size by Type
2.3.1 Rapid Microbiological Burden Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Rapid Microbiological Burden Testing Market Size Market Share by Type (2019-2024)
2.4 Rapid Microbiological Burden Testing Segment by Application
2.4.1 Industrial Testing
2.4.2 Clinical Disease Diagnosis
2.4.3 Research Applications
2.5 Rapid Microbiological Burden Testing Market Size by Application
2.5.1 Rapid Microbiological Burden Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Rapid Microbiological Burden Testing Market Size Market Share by Application (2019-2024)
3 Rapid Microbiological Burden Testing Market Size by Player
3.1 Rapid Microbiological Burden Testing Market Size Market Share by Player
3.1.1 Global Rapid Microbiological Burden Testing Revenue by Player (2019-2024)
3.1.2 Global Rapid Microbiological Burden Testing Revenue Market Share by Player (2019-2024)
3.2 Global Rapid Microbiological Burden Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rapid Microbiological Burden Testing by Region
4.1 Rapid Microbiological Burden Testing Market Size by Region (2019-2024)
4.2 Global Rapid Microbiological Burden Testing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Rapid Microbiological Burden Testing Market Size Growth (2019-2024)
4.4 APAC Rapid Microbiological Burden Testing Market Size Growth (2019-2024)
4.5 Europe Rapid Microbiological Burden Testing Market Size Growth (2019-2024)
4.6 Middle East & Africa Rapid Microbiological Burden Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Rapid Microbiological Burden Testing Market Size by Country (2019-2024)
5.2 Americas Rapid Microbiological Burden Testing Market Size by Type (2019-2024)
5.3 Americas Rapid Microbiological Burden Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Microbiological Burden Testing Market Size by Region (2019-2024)
6.2 APAC Rapid Microbiological Burden Testing Market Size by Type (2019-2024)
6.3 APAC Rapid Microbiological Burden Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rapid Microbiological Burden Testing Market Size by Country (2019-2024)
7.2 Europe Rapid Microbiological Burden Testing Market Size by Type (2019-2024)
7.3 Europe Rapid Microbiological Burden Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid Microbiological Burden Testing by Region (2019-2024)
8.2 Middle East & Africa Rapid Microbiological Burden Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Rapid Microbiological Burden Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rapid Microbiological Burden Testing Market Forecast
10.1 Global Rapid Microbiological Burden Testing Forecast by Region (2025-2030)
10.1.1 Global Rapid Microbiological Burden Testing Forecast by Region (2025-2030)
10.1.2 Americas Rapid Microbiological Burden Testing Forecast
10.1.3 APAC Rapid Microbiological Burden Testing Forecast
10.1.4 Europe Rapid Microbiological Burden Testing Forecast
10.1.5 Middle East & Africa Rapid Microbiological Burden Testing Forecast
10.2 Americas Rapid Microbiological Burden Testing Forecast by Country (2025-2030)
10.2.1 United States Market Rapid Microbiological Burden Testing Forecast
10.2.2 Canada Market Rapid Microbiological Burden Testing Forecast
10.2.3 Mexico Market Rapid Microbiological Burden Testing Forecast
10.2.4 Brazil Market Rapid Microbiological Burden Testing Forecast
10.3 APAC Rapid Microbiological Burden Testing Forecast by Region (2025-2030)
10.3.1 China Rapid Microbiological Burden Testing Market Forecast
10.3.2 Japan Market Rapid Microbiological Burden Testing Forecast
10.3.3 Korea Market Rapid Microbiological Burden Testing Forecast
10.3.4 Southeast Asia Market Rapid Microbiological Burden Testing Forecast
10.3.5 India Market Rapid Microbiological Burden Testing Forecast
10.3.6 Australia Market Rapid Microbiological Burden Testing Forecast
10.4 Europe Rapid Microbiological Burden Testing Forecast by Country (2025-2030)
10.4.1 Germany Market Rapid Microbiological Burden Testing Forecast
10.4.2 France Market Rapid Microbiological Burden Testing Forecast
10.4.3 UK Market Rapid Microbiological Burden Testing Forecast
10.4.4 Italy Market Rapid Microbiological Burden Testing Forecast
10.4.5 Russia Market Rapid Microbiological Burden Testing Forecast
10.5 Middle East & Africa Rapid Microbiological Burden Testing Forecast by Region (2025-2030)
10.5.1 Egypt Market Rapid Microbiological Burden Testing Forecast
10.5.2 South Africa Market Rapid Microbiological Burden Testing Forecast
10.5.3 Israel Market Rapid Microbiological Burden Testing Forecast
10.5.4 Turkey Market Rapid Microbiological Burden Testing Forecast
10.6 Global Rapid Microbiological Burden Testing Forecast by Type (2025-2030)
10.7 Global Rapid Microbiological Burden Testing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Rapid Microbiological Burden Testing Forecast
11 Key Players Analysis
11.1 Boehringer Ingelheim International GmbH
11.1.1 Boehringer Ingelheim International GmbH Company Information
11.1.2 Boehringer Ingelheim International GmbH Rapid Microbiological Burden Testing Product Offered
11.1.3 Boehringer Ingelheim International GmbH Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Boehringer Ingelheim International GmbH Main Business Overview
11.1.5 Boehringer Ingelheim International GmbH Latest Developments
11.2 Zoetis, Inc.
11.2.1 Zoetis, Inc. Company Information
11.2.2 Zoetis, Inc. Rapid Microbiological Burden Testing Product Offered
11.2.3 Zoetis, Inc. Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Zoetis, Inc. Main Business Overview
11.2.5 Zoetis, Inc. Latest Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Information
11.3.2 Merck & Co., Inc. Rapid Microbiological Burden Testing Product Offered
11.3.3 Merck & Co., Inc. Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck & Co., Inc. Main Business Overview
11.3.5 Merck & Co., Inc. Latest Developments
11.4 Bimeda, Inc.
11.4.1 Bimeda, Inc. Company Information
11.4.2 Bimeda, Inc. Rapid Microbiological Burden Testing Product Offered
11.4.3 Bimeda, Inc. Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bimeda, Inc. Main Business Overview
11.4.5 Bimeda, Inc. Latest Developments
11.5 Elanco Animal Health, Inc.
11.5.1 Elanco Animal Health, Inc. Company Information
11.5.2 Elanco Animal Health, Inc. Rapid Microbiological Burden Testing Product Offered
11.5.3 Elanco Animal Health, Inc. Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Elanco Animal Health, Inc. Main Business Overview
11.5.5 Elanco Animal Health, Inc. Latest Developments
11.6 Virbac
11.6.1 Virbac Company Information
11.6.2 Virbac Rapid Microbiological Burden Testing Product Offered
11.6.3 Virbac Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Virbac Main Business Overview
11.6.5 Virbac Latest Developments
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Information
11.7.2 Ceva Sante Animale Rapid Microbiological Burden Testing Product Offered
11.7.3 Ceva Sante Animale Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Ceva Sante Animale Main Business Overview
11.7.5 Ceva Sante Animale Latest Developments
11.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
11.8.1 CZ Vaccines S.A.U. (Zendal Health S.A.) Company Information
11.8.2 CZ Vaccines S.A.U. (Zendal Health S.A.) Rapid Microbiological Burden Testing Product Offered
11.8.3 CZ Vaccines S.A.U. (Zendal Health S.A.) Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 CZ Vaccines S.A.U. (Zendal Health S.A.) Main Business Overview
11.8.5 CZ Vaccines S.A.U. (Zendal Health S.A.) Latest Developments
11.9 Indian Immunologicals Ltd. (National Dairy Development Board)
11.9.1 Indian Immunologicals Ltd. (National Dairy Development Board) Company Information
11.9.2 Indian Immunologicals Ltd. (National Dairy Development Board) Rapid Microbiological Burden Testing Product Offered
11.9.3 Indian Immunologicals Ltd. (National Dairy Development Board) Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Indian Immunologicals Ltd. (National Dairy Development Board) Main Business Overview
11.9.5 Indian Immunologicals Ltd. (National Dairy Development Board) Latest Developments
11.10 Vaxxinova International BV (EW Group)
11.10.1 Vaxxinova International BV (EW Group) Company Information
11.10.2 Vaxxinova International BV (EW Group) Rapid Microbiological Burden Testing Product Offered
11.10.3 Vaxxinova International BV (EW Group) Rapid Microbiological Burden Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Vaxxinova International BV (EW Group) Main Business Overview
11.10.5 Vaxxinova International BV (EW Group) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂